Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2005 1
2006 1
2007 1
2009 3
2011 2
2012 5
2013 5
2014 7
2015 8
2016 7
2017 10
2018 7
2019 12
2020 4
2021 10
2022 9
2023 4
2024 9
2025 7
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment.
Hirschtritt ME, Bloch MH, Mathews CA. Hirschtritt ME, et al. JAMA. 2017 Apr 4;317(13):1358-1367. doi: 10.1001/jama.2017.2200. JAMA. 2017. PMID: 28384832 Review.
IMPORTANCE: Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder associated with significant impairment and a lifetime prevalence of 1% to 3%; however, it is often missed in primary care settings and frequently undertreated. ...Preliminar …
IMPORTANCE: Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder associated with significant impai …
"N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review".
Parli GM, Gales MA, Gales BJ. Parli GM, et al. Ann Pharmacother. 2023 Jul;57(7):847-854. doi: 10.1177/10600280221138092. Epub 2022 Nov 16. Ann Pharmacother. 2023. PMID: 36384314 Review.
OBJECTIVE: To evaluate clinical data using oral n-acetylcysteine (NAC) in obsessive-compulsive and related disorders (OCDRD) treatment. DATA SOURCES: PubMed, Ovid MEDLINE (1946-July 2022), and the Cochrane Library database were searched using the terms …
OBJECTIVE: To evaluate clinical data using oral n-acetylcysteine (NAC) in obsessive-compulsive and related disor …
N-acetylcysteine Clinical Applications.
Yahia Z, Yahia A, Abdelaziz T. Yahia Z, et al. Cureus. 2024 Oct 24;16(10):e72252. doi: 10.7759/cureus.72252. eCollection 2024 Oct. Cureus. 2024. PMID: 39450216 Free PMC article. Review.
This study aims to evaluate the therapeutic application of N-acetylcysteine (NAC) as a treatment or adjunct therapy for various medical conditions. ...It may be beneficial for polycystic ovary syndrome, endometriosis, male infertility, cataracts, glaucoma, dry eye s …
This study aims to evaluate the therapeutic application of N-acetylcysteine (NAC) as a treatment or adjunct therapy for variou …
The safety and efficacy of N-acetylcysteine as an augmentation in the treatment of obsessive-compulsive disorder in adults: a systematic review and meta-analysis of randomized clinical trials.
Eghdami S, Eissazade N, Heidari Mokarar M, Boroon M, Orsolini L, Shalbafan M. Eghdami S, et al. Front Psychiatry. 2024 Sep 23;15:1421150. doi: 10.3389/fpsyt.2024.1421150. eCollection 2024. Front Psychiatry. 2024. PMID: 39376972 Free PMC article.
BACKGROUND: Obsessive-compulsive disorder (OCD) ranks as the fourth most prevalent psychiatric disorder, with selective serotonin reuptake inhibitors (SSRIs) as its mainstay pharmacological treatment. ...The primary outcome of interest was the mean dif …
BACKGROUND: Obsessive-compulsive disorder (OCD) ranks as the fourth most prevalent psychiatric disorder, with se …
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Spielholz C, Frye R. Deepmala, et al. Neurosci Biobehav Rev. 2015 Aug;55:294-321. doi: 10.1016/j.neubiorev.2015.04.015. Epub 2015 May 6. Neurosci Biobehav Rev. 2015. PMID: 25957927 Free article.
N-acetylcysteine (NAC) is recognized for its role in acetaminophen overdose and as a mucolytic. ...In this systematic review we find favorable evidence for the use of NAC in several psychiatric and neurological disorders, particularly autism, Alzheimer's disease, co …
N-acetylcysteine (NAC) is recognized for its role in acetaminophen overdose and as a mucolytic. ...In this systematic review w …
The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review.
Lee DK, Lipner SR. Lee DK, et al. Int J Environ Res Public Health. 2022 May 24;19(11):6370. doi: 10.3390/ijerph19116370. Int J Environ Res Public Health. 2022. PMID: 35681955 Free PMC article. Review.
Recently, there is a growing interest in N-acetylcysteine (NAC) for treating BFRBs. NAC is a glutamate modulator that has shown promise in successfully reducing the compulsive behaviors in BFRB disorders. This article provides an updated review of the literat …
Recently, there is a growing interest in N-acetylcysteine (NAC) for treating BFRBs. NAC is a glutamate modulator that has show …
Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence.
Couto JP, Moreira R. Couto JP, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:245-254. doi: 10.1016/j.pnpbp.2018.06.005. Epub 2018 Jun 15. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29908912
Obsessive-compulsive disorder (OCD) is characterized by the presence of obsessions and/or compulsions. ...This work aims to systematically review the current evidence available concerning the efficacy of N-acetylcysteine (NAC) in the treatment o …
Obsessive-compulsive disorder (OCD) is characterized by the presence of obsessions and/or compulsions. ...This work aim …
N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
Li F, Welling MC, Johnson JA, Coughlin C, Mulqueen J, Jakubovski E, Coury S, Landeros-Weisenberger A, Bloch MH. Li F, et al. J Child Adolesc Psychopharmacol. 2020 Feb;30(1):32-37. doi: 10.1089/cap.2019.0041. Epub 2019 Dec 3. J Child Adolesc Psychopharmacol. 2020. PMID: 31800306 Free PMC article. Clinical Trial.
Background: Many children and adults with Obsessive-Compulsive Disorder (OCD) fail to respond to first-line pharmacological and behavioral treatments. ...The primary outcome was OCD symptom severity as measured by the Children's Yale-Brown Obsessive- …
Background: Many children and adults with Obsessive-Compulsive Disorder (OCD) fail to respond to first-line pharmacolog …
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS, de Barros PMF, de Mathis MA, Boavista R, Chacon P, Echevarria MAN, Ferrão YA, Vattimo EFQ, Lopes AC, Torres AR, Diniz JB, Fontenelle LF, Rosário MCD, Shavitt RG, Miguel EC, da Silva RMF, Costa DLDC. de Oliveira MVS, et al. Braz J Psychiatry. 2023 May 11;45(2):146-161. doi: 10.47626/1516-4446-2022-2891. Braz J Psychiatry. 2023. PMID: 36749887 Free PMC article.
OBJECTIVES: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with obsessive-compulsive disorder (OCD). METHODS: The American Psychiatric Association (APA) guidelines for the treatment of …
OBJECTIVES: To summarize evidence-based pharmacological treatments and provide guidance on clinical interventions for adult patients with …
102 results